Generic Name and Formulations:
Ketoconazole 2%; topical gel (anhydrous).
Indications for XOLEGEL:
Topical treatment of seborrheic dermatitis in immunocompetent patients.
Apply a thin layer to affected area(s) once daily for 2 weeks. Wash hands before and after use. Do not wash treated areas for at least 3 hours after application. Wait at least 20 mins before applying cosmetics, sunscreen, etc.
Avoid eyes, lips, mucous membranes. If irritation occurs or if disease worsens, then the use of the medication should be discontinued. Product is flammable (avoid open flames, smoking while applying). Pregnancy (Cat.C). Nursing mothers.
Application site burning, headache.
Gel—45g; Xolegel Duo—1 kit (15g gel + 4oz Xolex shampoo [zinc pyrithione 1%]); or (15g gel + 1.7oz Head & Shoulders shampoo [zinc pyrithione 1%])
Clinical Pain Advisor Articles
- Deaths After Nonfatal Opioid Overdose: Causes and Risk Factors
- Treatment for Opioid Use Disorder Associated With Reduced Risk for Opioid-Related Deaths
- Opioid-Free Analgesia Use for Postsurgical Pain Limited
- Clonidine May Not Improve Post-Cesarean Delivery Analgesia
- No Added Value With Liposomal Bupivacaine Following TKA With Peripheral Nerve Block
- Recommendations for Perioperative Pain Management in Patients With Opioid Tolerance
- Vertebroplasty Comparable With Placebo for Acute Vertebral Compression Fractures
- Capsaicin 8% Patch May Be Effective in Neuropathic Pain
- Detox vs Medication-Assisted Treatment for Opioid Use Disorder in Pregnancy: Expert Roundtable
- Prior Authorization Policy May Help Reduce Long-Acting Opioid Use
- Opioid-Related Deaths Represent Significant Public Health Burden
- Addressing Confidentiality Concerns With Electronic Access to Pediatric Medical Records
- Opioid-Related Adverse Events Common After Invasive Procedures
- Diagnosis and Treatment of Migraine in Children Should Consider Atopy
- Led by AG Sessions, DOJ Declines to Defend ACA Against Federal Lawsuit